0001104659-20-066408.txt : 20200527
0001104659-20-066408.hdr.sgml : 20200527
20200527161536
ACCESSION NUMBER: 0001104659-20-066408
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200526
FILED AS OF DATE: 20200527
DATE AS OF CHANGE: 20200527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ahmed Mahiuddin
CENTRAL INDEX KEY: 0001799304
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 20915394
MAIL ADDRESS:
STREET 1: C/O Y-MABS THERAPEUTICS, INC.
STREET 2: 230 PARK AVENUE, SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
a4.xml
4
X0306
4
2020-05-26
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001799304
Ahmed Mahiuddin
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE, SUITE 3350
NEW YORK
NY
10169
0
1
0
0
Sr. VP and CSO
Common Stock
2020-05-26
4
S
0
50000
39.3847
D
150000
D
This transaction was executed in multiple trades at prices ranging from $39.000 to $39.8700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Ahmed Mahiuddin
2020-05-27